Dr Lal Path Labs Q2 net profit dips 4 percent at Rs 50.9 crore
New Delhi: Diagnostic chain Dr. Lal Path Labs reported a 3.96 percent dip in its consolidated net profit to Rs 50.9 crore for the September quarter of the current fiscal.
The company had posted a net profit of Rs 53 crore for the corresponding period of the previous fiscal, Dr. Lal PathLabs said in a BSE filing.
Consolidated revenue from operations of the company rose to Rs 278.1 crore for the quarter under consideration as against Rs 262.2 crore for the same period a year ago.
The board of the company has recommended an interim dividend of Rs 1.50 per equity share of Rs 10 each, Dr. Lal PathLabs said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd